Evidence map›Paper›PMID 35511780›Full record

ArticlePloS one2022

High quality genome annotation and expression visualisation of a mupirocin-producing bacterium.

Anthony S Haines, Steve G Kendrew, Nicola Crowhurst, Elton R Stephens, Jack Connolly, Joanne Hothersall, Claire E Miller, Andrew J Collis, Benjamin D Huckle, Christopher M Thomas

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. New Insights intoAntibiotics (Basel, Switzerland) · 2024
    Review
  4. Microbial Genomics: Innovative Targets and Mechanisms.Antibiotics (Basel, Switzerland) · 2023
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anthony S HainesSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.ORCID 0000-0003-2736-6371
Steve G KendrewManufacturing Science and Technology, GlaxoSmithKline, Worthing, West Sussex, United Kingdom.
Nicola CrowhurstManufacturing Science and Technology, GlaxoSmithKline, Worthing, West Sussex, United Kingdom.
Elton R StephensSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Jack ConnollySchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.ORCID 0000-0003-3643-5578
Joanne HothersallSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Claire E MillerSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Andrew J CollisManufacturing Science and Technology, GlaxoSmithKline, Worthing, West Sussex, United Kingdom.
Benjamin D HuckleManufacturing Science and Technology, GlaxoSmithKline, Worthing, West Sussex, United Kingdom.
Christopher M ThomasSchool of Biosciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom.ORCID 0000-0002-2810-0455
University of Birmingham · GBGlaxoSmithKline (United Kingdom) · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Pseudomonas strain NCIMB10586, in the P. fluorescens subgroup, produces the polyketide antibiotic mupirocin, and has potential as a host for industrial production of a range of valuable products. To underpin further studies on its genetics and physiology, we have used a combination of standard and atypical approaches to achieve a quality of the genome sequence and annotation, above current standards for automated pathways. Assembly of Illumina reads to a PacBio genome sequence created a retrospectively hybrid assembly, identifying and fixing 415 sequencing errors which would otherwise affect almost 5% of annotated coding regions. Our annotation pipeline combined automation based on related well-annotated genomes and stringent, partially manual, tests for functional features. The strain was close to P. synxantha and P. libaniensis and was found to be highly similar to a strain being developed as a weed-pest control agent in Canada. Since mupirocin is a secondary metabolite whose production is switched on late in exponential phase, we carried out RNAseq analysis over an 18 h growth period and have developed a method to normalise RNAseq samples as a group, rather than pair-wise. To review such data we have developed an easily interpreted way to present the expression profiles across a region, or the whole genome at a glance. At the 2-hour granularity of our time-course, the mupirocin cluster increases in expression as an essentially uniform bloc, although the mupirocin resistance gene stands out as being expressed at all the time points.

Indexed as

MupirocinPseudomonas fluorescensAnti-Bacterial AgentsMolecular Sequence AnnotationRetrospective StudiesSequence Analysis, DNAAnti-Bacterial AgentsMupirocin

Identifiers

PMID35511780
PMCPMC9070926
OpenAlexW4229077125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.